L-DOPA and Droxidopa: From Force Field Development to Molecular Docking into Human β<sub>2</sub>-Adrenergic Receptor
The increasing interest in the molecular mechanism of the binding of different agonists and antagonists to <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">β</mi></...
Main Authors: | Andrea Catte, Akash Deep Biswas, Giordano Mancini, Vincenzo Barone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/9/1393 |
Similar Items
-
Belly dancer syndrome improved by withdrawal of droxidopa and amantadine
by: Mihiro Kaga, et al.
Published: (2023-04-01) -
A Case of Adrenergic Urticaria Associated with Vitiligo
by: Caroline Lang, et al.
Published: (2016-12-01) -
Physiology and pharmacology of cardiovascular adrenergic system
by: Anastasios eLymperopoulos
Published: (2013-09-01) -
Retraction: Physiology and pharmacology of the cardiovascular adrenergic system.
by: Frontiers ePhysiology Editorial Office
Published: (2015-11-01) -
Different effects of prolonged β-adrenergic stimulation on heart and cerebral artery
by: Eunji Shin, et al.
Published: (2014-12-01)